dr now glp 1 drops Pentagon Coverage of GLP-1 Weight Loss Meds for Medicare-Eligible Retirees GLP-1 Drugs Fail to Provide
Description
At 24 months, 17.8 kg reduction from baseline (99.5 kg to 81.7 kg), BMI reduced by 5.5 kg/m (from 36.5 to 31.0 kg/m), maintaining 20.6% 3.2% weight loss, though 95% attrition limits clinical interpretability
Multiple trials, thousands of participants, and consistent results across different populations
However, early on, it was noted that insulin derived from pancreatic extracts [1] or as crude insulin preparations [2] sometimes first elevated blood glucose and then later decreased blood glucose levels
doi: 10.3389/fnins.2022.991779
